New England Capital Financial Advisors LLC Biogen Inc. Transaction History
New England Capital Financial Advisors LLC
- $205 Billion
- Q4 2024
A detailed history of New England Capital Financial Advisors LLC transactions in Biogen Inc. stock. As of the latest transaction made, New England Capital Financial Advisors LLC holds 63 shares of BIIB stock, worth $8,651. This represents 0.0% of its overall portfolio holdings.
Number of Shares
63
Previous 63
-0.0%
Holding current value
$8,651
Previous $12.2 Million
21.11%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding BIIB
# of Institutions
996Shares Held
130MCall Options Held
1.57MPut Options Held
2.25M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.3 Billion0.05% of portfolio
-
Primecap Management CO Pasadena, CA16MShares$2.2 Billion1.94% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.4MShares$1.02 Billion0.05% of portfolio
-
Wellington Management Group LLP Boston, MA4.93MShares$677 Million0.14% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $19.8B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...